The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype
- B Rueda1,
- J Broen2,
- O Torres1,
- C Simeon3,
- N Ortego-Centeno4,
- M M V A P Schrijvenaars5,
- M C Vonk2,
- V Fonollosa3,
- F H J van den Hoogen6,
- M J H Coenen5,
- J Sanchez-Román7,
- M A Aguirre-Zamorano8,
- R García-Portales9,
- A Pros10,
- M T Camps11,
- M A Gonzalez-Gay12,
- J Martin1,
- T R D J Radstake2,13
- 1Instituto de Parasitologia y Biomedicina Lopez-Neyra, CSIC, Granada, Spain
- 2Department of Rheumatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
- 3Servicio de Medinina Interna, Hospital Vall de Ebron, Barcelona, Spain
- 4Servicio de Medicina Interna, Hospital Clinico Universitario, Granada, Spain
- 5Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
- 6Sint Maartenskliniek Nijmegen, Nijmegen, The Netherlands
- 7Servicio de Medicina Interna. Hospital Virgen del Rocio, Seville, Spain
- 8Servicio de Reumatología. Hospital Reina Sofía, Cordoba, Spain
- 9Servicio Medicina Interna. Hospital Virgen de la Victoria, Malaga, Spain
- 10Servicio de Reumatología, Hospital del Mar, Barcelona, Spain
- 11Servicio de Medicina Interna, Hospital Carlos Haya, Malaga, Spain
- 12Servicio de Reumatología, Hospital Xeral-Calde, Lugo, Spain
- 13The Arthritis Center, Boston Medical Center, Boston, Massachusetts, USA
- T R D J Radstake, Department of Rheumatology, Radboud University Nijmegen Medical Center, Geert Grooteplein 8, 6500 HB Nijmegen, The Netherlands; T.Radstake{at}reuma.umcn.nl
- Accepted 10 August 2008
- Published Online First 19 August 2008
Abstract
Objectives: Multiple studies indicate the role of the interleukin (IL)-17/IL-23 axis in autoimmune diseases, including systemic sclerosis (SSc). The aim of the current study was to investigate the possible implication of the IL23R gene in SSc susceptibility and/or clinical phenotype.
Methods: An initial case–control study in 143 Dutch patients with SSc and geographically matched healthy individuals (n = 246) was carried out and followed by a replication study in a cohort of 365 Spanish patients with SSc and 515 healthy individuals. Seven single nucleotide polymorphisms (SNPs) spanning the IL23R gene were selected and genotyped using a Taqman assay.
Results: Using a Dutch cohort of patients with SSc and controls we observed an association between two (rs11209032, rs1495965) of the seven tested SNPs and disease susceptibility (allelic p values: p = 0.02 and p = 0.01 respectively). However, a replication study in an independent Spanish cohort did not confirm these findings and reveal no association of any of the IL23R-tested SNP with disease susceptibility or clinical phenotype. Similarly, a meta-analysis considering both populations did not reveal any significant association. In addition, no association was observed between IL23R genetic variants and SSc clinical phenotypes.
Conclusions: Our results suggest that the IL23R gene is not associated with SSc susceptibility or clinical phenotype.
Footnotes
-
Competing interests: None.








